Avatar for Remedy Plan Therapeutics

Remedy Plan is developing the first drugs that halt tumor growth and disrupt metastasis

Remedy Plan is developing the first drugs that halt tumor growth and disrupt metastasis

Remedy Plan Therapeutic's proprietary drug screening platform identifies drug candidates that differentiate cancer stem cells, disrupt proliferation, and inhibit formation of new tumors. From the initial screen of 40,000 drug components, an optimized lead candidate is in preparation for Phase I clinical trials. With the second screen of over 100,000 drug components completed, Remedy Plan aims to have at least two drugs in clinical development in 2020.
Founder Remedy Plan • Worked at @FDA • PhD from @University of California Berkeley
Total raised

$10.2M

Funded over

5 rounds

Latest round

Series A (Sep 2019)

Research Scientist I

Apply now